<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02402569</url>
  </required_header>
  <id_info>
    <org_study_id>SIV2</org_study_id>
    <nct_id>NCT02402569</nct_id>
  </id_info>
  <brief_title>Multi-electrodes Set for Deep Brain Stimulation in Parkinson Disease</brief_title>
  <acronym>SIV2</acronym>
  <official_title>Implantation Feasibility Study of a Multi-electrodes Set for Deep Brain Stimulation in Parkinson Disease (Smart in Vivo 2)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Grenoble</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital, Grenoble</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study aims to demonstrate innocuity and feasibility of deep brain stimulation with a
      multi-electrodes set.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Bilateral stimulation in subthalamic nucleus with the multi-electrodes set will be compared
      with single electrode.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>December 2014</start_date>
  <completion_date type="Anticipated">December 2021</completion_date>
  <primary_completion_date type="Anticipated">December 2019</primary_completion_date>
  <phase>Early Phase 1</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Safety, as measured by Number of Participants with Adverse Events</measure>
    <time_frame>3 months</time_frame>
    <description>Number of Participants with Adverse Events</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Neurologic evaluation</measure>
    <time_frame>3 months</time_frame>
    <description>Change in motor and non-motor symptoms assessment with neurologic scales</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">5</enrollment>
  <condition>Parkinson Disease</condition>
  <arm_group>
    <arm_group_label>Multi-electrodes / single electrode</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Multi stimulation / single stimulation</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Single-electrode / Multi electrodes</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Single stimulation / Multi stimulation</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>32 channels Deep Brain Stimulator</intervention_name>
    <arm_group_label>Multi-electrodes / single electrode</arm_group_label>
    <arm_group_label>Single-electrode / Multi electrodes</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  more or equal than 18 years old and less than 70 years

          -  patient affiliated to social security or similarly regime

          -  informed consent form signed

          -  parkinson disease (UPDRS III20 score up than 30/108 except for severe tremors)

          -  motor and non motor dysfunctions

          -  pre-operative cerebral MRI without lesion

          -  without chirurgical contraindications

          -  without psychiatric disease

        Exclusion Criteria:

          -  Pregnant women and lactating mothers

          -  Ward of court or under guardianship

          -  Adult unable to express their consent

          -  Person deprived of freedom by judicial or administrative decision

          -  Person hospitalized without their consent

          -  Person under legal protection

          -  Person with carcinological antecedent during precedent 5 years

          -  Chirurgical or MRI contraindications
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Alim-Louis BENABID, MD, PhD</last_name>
    <phone>+ 33 4 38 78 38 14</phone>
    <email>alimlouis@sfr.fr</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Caroline SANDRE-BALLESTER, PhD</last_name>
    <phone>+ 33 4 38 78 28 51</phone>
    <email>csandreballester@chu-grenoble.fr</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>CLINATEC</name>
      <address>
        <city>Grenoble</city>
        <zip>38000</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Alim-Louis BENABID, MD, PhD</last_name>
      <phone>+ 33 4 38 78 38 14</phone>
      <email>alimlouis@sfr.fr</email>
    </contact>
    <contact_backup>
      <last_name>Caroline SANDRE-BALLESTER, PhD</last_name>
      <phone>+ 33 4 38 78 28 51</phone>
      <email>csandreballester@chu-grenoble.fr</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>May 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>January 30, 2015</study_first_submitted>
  <study_first_submitted_qc>March 24, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 30, 2015</study_first_posted>
  <last_update_submitted>May 3, 2018</last_update_submitted>
  <last_update_submitted_qc>May 3, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">May 4, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Parkinson Disease</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

